YBGJ

$0.01-50.00%visit website

Yubo International Biotech Ltd

Market Cap

$920,272.266

Live price × SEC shares (Aug 11, 2026)

Sector

Health Care

Industry

Electromedical & Electrotherapeutic Apparatus

Beta (raw)

0.81

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

74.5

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.0	12.4	0.0	0.0	12.4
Cost of revenue	0.00	4.19	0.00	0.00	4.19
Gross profit	0.00	8.17	0.00	0.00	8.17
Total operating expenses	310	294	289	239	1,132
Operating income	(310)	(285)	(289)	(239)	(1,124)
Interest expense	0.02
Pretax income	(310)	(286)	(295)	(269)	(1,160)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(310)	(177)	(273)	(248)	(1,008)
EPS (diluted) ($)	0.00		0.00	0.00	(0.01)
Weighted avg. shares (diluted)	147,871		170,421	170,421

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 64 more quarters, back to Aug 2010, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Jan 16, 2026 accepted 4:05 PM ET	4.01Auditor change	Document SEC ↗
Jul 25, 2025 accepted 4:05 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Jan 10, 2025 accepted 6:01 AM ET	8-K/A 4.01Auditor change	Document SEC ↗
Jan 6, 2025 accepted 4:15 PM ET	4.01Auditor change	Document SEC ↗